AAAAAA
Results:
1-16
|
Results: 16
Authors:
Jagroop, IA
Mikhailidis, DP
Citation: Ia. Jagroop et Dp. Mikhailidis, Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter Thrombocytometer, PLATELETS, 12(3), 2001, pp. 171-171
Authors:
Jagroop, IA
Mikhailidis, DP
Citation: Ia. Jagroop et Dp. Mikhailidis, Doxazosin, an alpha(1)-adrenoceptor antagonist, inhibits serotonin-inducedshape change in human platelets, J HUM HYPER, 15(3), 2001, pp. 203-207
Authors:
Sullivan, ME
Miller, MAW
Bell, CRW
Jagroop, IA
Thompson, CS
Khan, MA
Morgan, RJ
Mikhailidis, DP
Citation: Me. Sullivan et al., Fibrinogen, lipoprotein (a) and lipids in patients with erectile dysfunction - A preliminary study, INT ANGIOL, 20(3), 2001, pp. 195-199
Authors:
Jagroop, IA
Mikhailidis, DP
Citation: Ia. Jagroop et Dp. Mikhailidis, Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofuryl, PLATELETS, 11(5), 2000, pp. 272-277
Authors:
Jagroop, IA
Mikhailidis, DP
Citation: Ia. Jagroop et Dp. Mikhailidis, An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models, PLATELETS, 11(3), 2000, pp. 161-165
Authors:
Jagroop, IA
Clatworthy, I
Lewin, J
Mikhailidis, DP
Citation: Ia. Jagroop et al., Shape change in human platelets: measurement with a channelyzer and visualisation by electron microscopy, PLATELETS, 11(1), 2000, pp. 28-32
Authors:
Jagroop, IA
Mikhailidis, DP
Citation: Ia. Jagroop et Dp. Mikhailidis, Angiotensin II can induce and potentiate shape change in human platelets: effect of losartarn, J HUM HYPER, 14(9), 2000, pp. 581-585
Authors:
Davis, M
Atwal, AS
Nair, DR
Jagroop, IA
Seifalian, AM
Mikhailidis, DP
Hamilton, G
Citation: M. Davis et al., The effect of short-term lipid lowering with atorvastatin on carotid artery intima media thickness in patients with peripherial vascular disease: A pilot study, CURR MED R, 16(3), 2000, pp. 198-204
Authors:
Dashwood, MR
Jagroop, IA
Gorog, DA
Bagger, JP
Citation: Mr. Dashwood et al., A potential role for endothelin-1 in peripheral vascular disease, J CARDIO PH, 36, 2000, pp. S93-S94
Authors:
Mikhailidis, DP
Jagroop, IA
Citation: Dp. Mikhailidis et Ia. Jagroop, Aspirin increases platelet sensitivity to adenosine diphosphate in patients with coronary artery disease, PLATELETS, 10(5), 1999, pp. 349-350
Authors:
Papadakis, JA
Ganotakis, ES
Jagroop, IA
Mikhailidis, DP
Winder, AF
Citation: Ja. Papadakis et al., Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia, AM J HYPERT, 12(7), 1999, pp. 673-681
Authors:
Jagroop, IA
Milionis, HJ
Mikhailidis, DP
Citation: Ia. Jagroop et al., Mechanism underlying increased platelet reactivity in patients with peripheral arterial disease, INT ANGIOL, 18(4), 1999, pp. 348-349
Authors:
Jagroop, IA
Berwanger, CS
Stansby, G
Mikhailidis, DP
Citation: Ia. Jagroop et al., Plasma endothelin-1 concentrations in non-insulin-dependent diabetes mellitus and nondiabetic patients with chronic arterial obstructive disease of the lower limbs, INT ANGIOL, 18(1), 1999, pp. 77-78
Authors:
Papadakis, JA
Ganotakis, ES
Jagroop, IA
Winder, AF
Mikhailidis, DP
Citation: Ja. Papadakis et al., Statin plus fibrate combination therapy - Fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease, INT J CARD, 69(3), 1999, pp. 237-244
Authors:
Jagroop, IA
Papadakis, JA
Mikhailidis, DP
Citation: Ia. Jagroop et al., 'Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension', PLATELETS, 9(6), 1998, pp. 395-396
Authors:
Mikhailidis, DP
Ganotakis, ES
Spyropoulos, KA
Jagroop, IA
Byrne, DJ
Winder, AF
Citation: Dp. Mikhailidis et al., Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice, INT ANGIOL, 17(4), 1998, pp. 225-233
Risultati:
1-16
|